
Collain Healthcare, An LG CNS Company, Unveils New Interactive Virtual Care Team™, An Enhanced Communication And Collaboration Platform To Serve The Long Term And Post-Acute Care Market
All-in-one platform delivers scalability, enhanced user experience and real-time interventions to empower remote virtual care across a wide range of settings
GEORGETOWN, Texas, May 1, 2015 /PRNewswire/ -- Collain Healthcare, an LG CNS Company, today announced the launch of the most advanced version of its telemedicine technology entry, Interactive Virtual Care Team™ (IVCT). Built to unify and empower the entire care team, IVCT combines comprehensive telehealth, remote patient monitoring, medication management and clinical decision support within a single platform.
Featuring patient-centered design, broad connectivity and unmatched scalability, IVCT was built for the evolving value-based era, exemplified by ACOs, managed care and bundled payment initiatives. LG CNS' development efforts, which date to the last decade, represent an unprecedented investment in the traditionally underserved post-acute market that includes transitions of care and chronic care management.
"This moves us past the patchwork of well-intended, but fragmented, legacy systems that drive other approaches," said Robert Choi, Chief Strategy Officer of Collain Healthcare. "Our platform delivers not only a longitudinal patient record, but more importantly, it unifies and leverages the power of distributed care teams of informal caregivers, family members, physicians and other providers."
With well-established global adoption and extensive development, IVCT delivers a unique combination of patient engagement, multi-modal communication, and the capacity for real-time interventions. The application recently received FDA Class II approval.
"When we look at the wide range of post-acute settings, from aging in place at home to nursing homes and to end-of-life and hospice, there is tremendous need for a fully integrated and comprehensive solution across the continuum of care," said Dr. Maryann Choi, CEO of Collain Healthcare.
The platform meets the needs of large population health initiatives with market-leading flexibility, quick deployments and a powerful capacity for a payer or provider to scale and manage as many as several million patient lives. It also fuels the adoption of payment reform advancements such as chronic care management and remote monitoring.
While designed from the perspective of the patient, the intuitive workflows were built from close collaboration with patients, family members, community-based workers, CNAs, nurses, primary care physicians, specialists and ER physicians. IVCT is part of an integrated suite of LGCNS' healthcare solutions that realize the growing benefits of real-time, proactive monitoring in a distributed healthcare delivery system.
"LG CNS' deep roots in exceptional consumer experiences provided uncommon insights into how we built this platform to reach patients wherever they are and however they want to connect to their care team," said Dr. KP Lee, Senior Leader of the Healthcare Business Group at LG CNS. "This platform will empower patients, families and caregivers in the US and globally to enable virtual connected care."
About Collain Healthcare
Collain Healthcare, an LG CNS company, is headquartered in Georgetown, TX, and is the exclusive US commercialization entity of LG CNS Healthcare Solutions. Led by a physician, the leadership team is comprised of experts with deep knowledge across the continuum of care. Collain Healthcare delivers state-of-the-art, smart technology with patient-centered digital health solutions for the global healthcare industry and in alignment with the Triple Aim. Clients benefit from the most advanced health information technology platform created from the ground up with customers, following the passage of ACA and focusing on the future of healthcare. For more information, visit healthcare.lgcns.com.
SOURCE Collain Healthcare
Share this article